Bachem

Company BCHMF

Last mentioned: Mar 24, 2026

Timeline

  1. Analyst Sentiment Review

    Major firms maintain ratings, citing steady execution of the strategic pivot.

  2. 2026 Guidance Issued

    Management outlines $72M-$76M revenue target driven by ECO Synthesis.

  3. Q4 2025 Earnings Release

    Codexis reports significant beats on both top and bottom lines.

Stories mentioning Bachem 2

pharma Neutral

Bachem Earnings Preview: Peptide Capacity and GLP-1 Demand in Focus

Bachem (BCHMF) is set to release its quarterly earnings this Thursday, with investors closely monitoring the Swiss CDMO's ability to scale production for the booming GLP-1 market. As a critical supplier of peptides and oligonucleotides, Bachem's financial performance and capacity expansion updates will serve as a bellwether for the broader weight-loss drug supply chain.

2 sources

About Bachem coverage

This page surfaces every story mentioning Bachem across our biotech coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.

Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running biotech beat. Cross-entity comparisons live on our compare view.

What you seeWhat it tells you
Story countNumber of distinct stories where Bachem was a primary or referenced actor.
Recency clusteringWhether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc).
Sentiment distributionAggregate sentiment of the stories mentioning this entity, weighted by impact score.
Cross-niche linksWhen the same entity surfaces in our sibling networks, we link to those views to enrich context.